Position in JNJ
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$18,580,862
+$2,812,307 QoQ
Shares Held
76,014
-0.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.98%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Reynders McVeigh Capital Management, LLC holds $48,961,420 across 8 Drug Manufacturers - General names. JNJ ranks #1 (38.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
76,014 | $18,580,862 | |
| 2 | NVS |
Novartis AG
|
73,392 | $11,210,628 | |
| 3 | ABBV |
AbbVie Inc.
|
29,052 | $6,318,519 | |
| 4 | LLY |
ELI LILLY & Co
|
5,986 | $5,505,743 | |
| 5 | AMGN |
Amgen Inc
|
9,182 | $3,230,686 | |
| 6 | MRK |
Merck & Co., Inc.
|
22,387 | $2,692,932 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,904 | $1,085,877 | |
| 8 | PFE |
Pfizer Inc
|
11,972 | $336,173 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,580,862 | 76,014 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $15,768,555 | 76,195 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $14,573,455 | 78,597 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $11,735,171 | 76,826 | Shares | Sole | 2025-09-04 | |
| 2025-03-31 | $13,501,863 | 81,415 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $12,367,902 | 85,520 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $14,257,066 | 87,974 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,236,395 | 90,561 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $14,899,916 | 94,190 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $15,051,271 | 96,027 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $15,471,582 | 99,336 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $16,924,254 | 102,249 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $15,274,940 | 98,548 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $17,907,893 | 101,375 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $17,663,136 | 108,124 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $19,883,427 | 112,013 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $20,370,284 | 114,937 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $19,713,764 | 115,238 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $19,006,935 | 117,690 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $19,622,840 | 119,114 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $19,880,926 | 120,967 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $19,329,883 | 122,823 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $18,065,843 | 121,345 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $17,257,269 | 122,714 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $15,688,655 | 119,642 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||